Other reports have identified the importance of the PI3K pathway and integrin-VLA-4 signaling in facilitating BTKi resistance or enhanced focal adhesion kinase (FAK) or CXCR4 activity in MCL during MCL–stromal cell interaction [49–51]. The gene discussed is CXCR4; the disease is mantle cell lymphoma.